137 related articles for article (PubMed ID: 35072591)
21. Investigation of the sensitization rate for gibberellin-regulated protein in patients with Japanese cedar pollinosis.
Mori Y; Okazaki F; Momma K; Narita H; Kondo Y
Allergol Immunopathol (Madr); 2022; 50(2):89-92. PubMed ID: 35257550
[TBL] [Abstract][Full Text] [Related]
22. Latent 1,3-β-D-glucan acts as an adjuvant for allergen-specific IgE production induced by Japanese cedar pollen exposure.
Kanno T; Adachi Y; Ohashi-Doi K; Matsuhara H; Hiratsuka R; Ishibashi KI; Yamanaka D; Ohno N
Allergol Int; 2021 Jan; 70(1):105-113. PubMed ID: 32919904
[TBL] [Abstract][Full Text] [Related]
23. A 13-year study of Japanese cedar pollinosis in Japanese schoolchildren.
Ozasa K; Hama T; Dejima K; Watanabe Y; Hyo S; Terada T; Araki N; Takenaka H
Allergol Int; 2008 Jun; 57(2):175-80. PubMed ID: 18427167
[TBL] [Abstract][Full Text] [Related]
24. Mapping naso-ocular symptom scores to EQ-5D-5L utility values in Japanese cedar pollinosis.
Kumanomidou H; Kanai K; Oka A; Haruna T; Hirata Y; Makihara SI; Higaki T; Akamatsu M; Okamoto Y; Ikeda S; Okano M
Allergol Int; 2022 Apr; 71(2):207-213. PubMed ID: 34872827
[TBL] [Abstract][Full Text] [Related]
25. Seasonal omalizumab reduces allergen-specific immunoglobulin E levels in patients with Japanese cedar pollinosis and asthma.
Hamada S; Yasuba H
Rev Port Pneumol (2006); 2017; 23(6):365-367. PubMed ID: 29042155
[No Abstract] [Full Text] [Related]
26. [Quality of life in patients with Japanese cedar pollinosis: using the SF-8 health status questionnaire (Japanese version)].
Fujii T; Ogino S; Arimoto H; Irifune M; Iwata N; Ookawachi I; Kikumori H; Seo R; Takeda M; Tamaki A; Baba K; Nose M
Arerugi; 2006 Oct; 55(10):1288-94. PubMed ID: 17072108
[TBL] [Abstract][Full Text] [Related]
27. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.
Nagao M; Hiraguchi Y; Hosoki K; Tokuda R; Usui T; Masuda S; Yamaguchi M; Fujisawa T
Int Arch Allergy Immunol; 2008; 146 Suppl 1():47-53. PubMed ID: 18504407
[TBL] [Abstract][Full Text] [Related]
28. Analysis of natural history of Japanese cedar pollinosis.
Okawa T; Konno A; Yamakoshi T; Numata T; Terada N; Shima M
Int Arch Allergy Immunol; 2003 May; 131(1):39-45. PubMed ID: 12759488
[TBL] [Abstract][Full Text] [Related]
29. Eicosanoids seasonally impact pulmonary function in asthmatic patients with Japanese cedar pollinosis.
Soma T; Uchida Y; Nakagome K; Hoshi R; Nagata M
Allergol Int; 2020 Oct; 69(4):594-600. PubMed ID: 32600924
[TBL] [Abstract][Full Text] [Related]
30. Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis.
Noyama Y; Okano M; Fujiwara T; Kariya S; Makihara S; Haruna T; Kanai K; Higaki T; Nishizaki K
Allergol Int; 2016 Jul; 65(3):259-65. PubMed ID: 26907728
[TBL] [Abstract][Full Text] [Related]
31. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
[TBL] [Abstract][Full Text] [Related]
32. Two thirds of forest walkers with Japanese cedar pollinosis visit forests even during the pollen season.
Morita E; Nagano J; Yamamoto H; Murakawa I; Aikawa M; Shirakawa T
Allergol Int; 2009 Sep; 58(3):383-8. PubMed ID: 19542767
[TBL] [Abstract][Full Text] [Related]
33. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
34. [SYMPTOMS AND HINDRANCES DUE TO PEDIATRIC JCP EVALUATED BY PATIENTS AND THEIR PARENTS].
Masuda S; Usui S
Arerugi; 2015 Jul; 64(7):942-51. PubMed ID: 26464368
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of rice seed-based oral allergy vaccine for Japanese cedar pollinosis in Japanese monkeys.
Saito S; Takagi H; Wakasa Y; Ozawa K; Takaiwa F
Mol Immunol; 2020 Sep; 125():63-69. PubMed ID: 32650161
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of Japanese cedar pollinosis throughout Japan.
Okuda M
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):288-96. PubMed ID: 14533662
[TBL] [Abstract][Full Text] [Related]
37. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study.
Kawase M; He F; Kubota A; Hiramatsu M; Saito H; Ishii T; Yasueda H; Akiyama K
Int J Food Microbiol; 2009 Jan; 128(3):429-34. PubMed ID: 18977549
[TBL] [Abstract][Full Text] [Related]
38. [Correlation between the SF-8 health status questionnaire and JRQLQ in patients with Japanese cedar pollinosis].
Fujii T; Ogino S; Arimoto H; Irifune M; Iwata N; Ookawachi I; Kikumori H; Seo R; Takeda M; Tamaki A; Baba K; Nose M
Arerugi; 2007 Feb; 56(2):109-17. PubMed ID: 17347597
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness Analysis of Omalizumab for Severe Allergic Asthma in Japan Using Real-World Evidence.
Igarashi A; Kaur H; Choubey A; Popli A; Muthukumar M; Yoshisue H; Funakubo M; Ohta K
Value Health Reg Issues; 2022; 27():41-48. PubMed ID: 34784547
[TBL] [Abstract][Full Text] [Related]
40. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Int J Cancer; 2022 Feb; 150(4):580-593. PubMed ID: 34569617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
